| Objective:To explore the effect of short-term hyperoxia on the mitochondrial Ca2+/nicotinamide adenine dinucleotide(NAD+)/silencing information regulatory factor 3(SIRT3)/superoxide dismutase 2(SOD2)pathway and reactive oxygen species(ROS)production in alveolar typeⅡepithelial cells(AECⅡ).Methods:The same generation cells of rat alveolar typeⅡepithelial cell line(RLE-6TN)were randomly divided into a control group,a hyperoxia group and a mitochondrial calcium channel antagonist group(antagonist group).Cells in group H were placed in a hyperoxia box with an oxygen concentration of 90%for 4 hours,cells in group C were placed in a conventional cell incubator for 4 hours,cells in group HR were placed in an oxygen concentration of 90%after adding ruthenium red(2umol/L)4 hours in the high-oxygen box.Cell messenger RNA(messenger RNA,m RNA)was then extracted,and the levels of silencing information regulator(SIRT3)and superoxide dismutase 2(SOD2)m RNA were analyzed by real-time fluorescent quantitative PCR;the mitochondrial calcium ion specific fluorescent probe Rhod--2-AM detects cell mitochondrial Ca2+content;uses Coenzyme I amide adenine dinucleotide/reduced nicotinamide adenine dinucleotide(NAD+/NADH)content kit to measure the content and ratio of NAD+and NADH;use activity The oxygen detection kit detects the level of ROS.Results:Compared with the control group and the antagonist group,in the hyperoxia group,the cell NAD+content,NAD+/NADH ratio,SIRT3 and SOD2 m RNA expression levels were significantly reduced,and the cell mitochondrial Ca2+content,NADH content and ROS production were significantly increased,and the difference was statistically significant(P<0.05).Compared with the control group,the cell Ca2+content,NAD+/NADH ratio and ROS content of the antagonist group were significantly reduced,and the difference was statistically significant(P<0.05).There was no statistical difference in cell NAD+content,NADH content,SIRT3 and SOD2m RNA expression levels.Conclusions:Short-term hyperoxia can increase the production of ROS by the Ca2+/NAD+/SIRT3/SOD2 pathway in AECⅡ. |